Gerontology Research Center Tissue Procurement for Biomedical Research
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/5/2014 |
| Start Date: | February 2003 |
| End Date: | December 2018 |
| Contact: | Josephine M Egan, M.D. |
| Email: | eganj@mail.nih.gov |
| Phone: | (410) 558-8414 |
Tissue Procurement for Biomedical Research
The need to obtain human tissue (blood, urine, saliva, sweat, pleural, pericardia\, ascitic,
synovial, cerebrospinal fluids) for methods development and disease correlation is frequent
in Gerontology Research Center laboratories. This protocol is to create the opportunity to
obtain such tissue samples that have been obtained during the course of usual clinical care
and would be discarded, or alternatively, to obtain such samples during subject and patient
screening for other studies (in this case only blood, urine, saliva, or sweat).
Information derived from such studies is for research purposes only and is not provided to
the patient/subject or their health care provider. When genetic analyses are performed,
samples will have been coded and identifying information linking patient/subject to the
sample will be destroyed. Any genetic information obtained will have no established
clinical value and will not be provided to the subject/patient or their health care
provider.
Patients included will be those 18 years or older and who have been identified by the
investigator to have a condition of interest for exploratory studies related to the
patient's illness or other feature that offers the possibility of creating information that
leads to scientifically useful and important studies. Patients will be excluded if
obtaining the sample would be over and above usual clinical care, would result in excessive
blood loss, or the individual is unable to provide informed consent.
The expected outcome is to provide the investigator the opportunity to obtain tissues of
interest for laboratory evaluation with the goal of either better understanding a disease or
to design a scientific study to better understand or treat a disease.
synovial, cerebrospinal fluids) for methods development and disease correlation is frequent
in Gerontology Research Center laboratories. This protocol is to create the opportunity to
obtain such tissue samples that have been obtained during the course of usual clinical care
and would be discarded, or alternatively, to obtain such samples during subject and patient
screening for other studies (in this case only blood, urine, saliva, or sweat).
Information derived from such studies is for research purposes only and is not provided to
the patient/subject or their health care provider. When genetic analyses are performed,
samples will have been coded and identifying information linking patient/subject to the
sample will be destroyed. Any genetic information obtained will have no established
clinical value and will not be provided to the subject/patient or their health care
provider.
Patients included will be those 18 years or older and who have been identified by the
investigator to have a condition of interest for exploratory studies related to the
patient's illness or other feature that offers the possibility of creating information that
leads to scientifically useful and important studies. Patients will be excluded if
obtaining the sample would be over and above usual clinical care, would result in excessive
blood loss, or the individual is unable to provide informed consent.
The expected outcome is to provide the investigator the opportunity to obtain tissues of
interest for laboratory evaluation with the goal of either better understanding a disease or
to design a scientific study to better understand or treat a disease.
The need to obtain human tissue (blood, urine, saliva, sweat, pleural, pericardial, ascitic,
synovial, cerebrospinal fluids) for methods development and disease correlation is frequent
in Gerontology Research Center laboratories. This protocol is to create the opportunity to
obtain such tissue samples that have been obtained during the course of usual clinical care
and would be discarded, or alternatively, to obtain such samples during subject and patient
screening for other studies (in this case only blood, urine, saliva, or sweat).
Information derived from such studies is for research purposes only and is not provided to
the patient/subject or their health care provider. When genetic analyses are performed,
samples will have been coded and identifying information linking patient/subject to the
sample will be destroyed. Any genetic information obtained will have no established clinical
value and will not be provided to the subject/patient or their health care provider.
Patients included will be those 18 years or older and who have been identified by the
investigator to have a condition of interest for exploratory studies related to the patient
s illness or other feature that offers the possibility of creating information that leads
to scientifically useful and important studies. Patients will be excluded if obtaining the
sample would be over and above usual clinical care, would result in excessive blood loss, or
the individual is unable to provide informed consent.
The expected outcome is to provide the investigator the opportunity to obtain tissues of
interest for laboratory evaluation with the goal of either better understanding a disease or
to design a scientific study to better understand or treat a disease.
synovial, cerebrospinal fluids) for methods development and disease correlation is frequent
in Gerontology Research Center laboratories. This protocol is to create the opportunity to
obtain such tissue samples that have been obtained during the course of usual clinical care
and would be discarded, or alternatively, to obtain such samples during subject and patient
screening for other studies (in this case only blood, urine, saliva, or sweat).
Information derived from such studies is for research purposes only and is not provided to
the patient/subject or their health care provider. When genetic analyses are performed,
samples will have been coded and identifying information linking patient/subject to the
sample will be destroyed. Any genetic information obtained will have no established clinical
value and will not be provided to the subject/patient or their health care provider.
Patients included will be those 18 years or older and who have been identified by the
investigator to have a condition of interest for exploratory studies related to the patient
s illness or other feature that offers the possibility of creating information that leads
to scientifically useful and important studies. Patients will be excluded if obtaining the
sample would be over and above usual clinical care, would result in excessive blood loss, or
the individual is unable to provide informed consent.
The expected outcome is to provide the investigator the opportunity to obtain tissues of
interest for laboratory evaluation with the goal of either better understanding a disease or
to design a scientific study to better understand or treat a disease.
- INCLUSION CRITERIA:
- Age 18 or older.
- Identified by the investigator to have a condition of interest for exploratory
studies related to the patient s illness or other feature that offers the
possibility of generation of hypotheses for future study.
EXCLUSION CRITERIA:
- The patient would be subjected to diagnostic and/or therapeutic procedures that are
not necessary for clinical management.
- Excessive blood loss if this phlebotomy plus other research participation and/or
clinical evaluation will result in blood loss of greater than 1 unit (400 ml, 1 pint)
over an 8-week period.
Inability of the volunteer to give informed consent.
We found this trial at
3
sites
Click here to add this to my saved trials
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
Click here to add this to my saved trials
Click here to add this to my saved trials